Immunology: Divergent immunoglobulin G subclass activity through selective Fc receptor binding

Science

Volumn 310, Issue 5753, 2005, Pages 1510-1512

  Nimmerjahn, Falk ^a   Ravetch, Jeffrey V ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; TUMORS; VACCINES;

IMMUNOGLOBULIN G (IGG); MICROBES; THERAPEUTIC ANTIBODIES;

IMMUNOLOGY;

ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; VACCINE;

MEDICINE;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CELL FUNCTION; CROSS LINKING; CYTOKINE RELEASE; EFFECTOR CELL; HELPER CELL; MEDIATOR RELEASE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PREDICTION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; ANIMAL; C57BL MOUSE; CELL LINE; CLASSIFICATION; FEMALE; IMMUNOLOGY; MELANOSOME; METABOLISM; PROTEIN BINDING; THROMBOCYTE;

ANIMALIA;

ANIMALS; BLOOD PLATELETS; CELL LINE; FEMALE; IMMUNOGLOBULIN G; MELANOSOMES; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RECEPTORS, IGG;

EID: 28544449847     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1118948     Document Type: Article

References (26)

1. G. W. Litman, M. K. Anderson, J. P. Rast, Annu. Rev. Immunol. 17, 109 (1999).
2. D. R. Burton, J. M. Woof, Adv. Immunol. 51, 1 (1992).
3. J. V. Ravetch, S. Bolland, Annu. Rev. Immunol. 19, 275 (2001).
4. F. D. Finkelman et al., Annu. Rev. Immunol. 8, 303 (1990).
5. J. Stavnezer, J. Immunol. 155, 1647 (1995).
6. C. M. Snapper, J. J. Mond, Immunol. Today 14, 15 (1993).
7. T. R. Mosmann, R. L. Coffman, Annu. Rev. Immunol. 7, 145 (1989).
8. J. J. Mond, Q. Vos, A. Lees, C. M. Snapper, Curr. Opin. Immunol. 7, 349 (1995).
9. J. P. Coutelier, J. T. van der Logt, F. W. Heessen, G. Warnier, J. Van Snick, J. Exp. Med. 165, 64 (1987).
10. D. Markine-Goriaynoff, J. P. Coutelier, J. Virol. 76, 432 (2002).
11. L. Fossati-Jimack et al., Exp. Med. 191, 1293 (2000).
12. A. R. Duncan, G. Winter, Nature 332, 738 (1998).
13. C. A. Janeway, P. Travers, M. Walport, M. Shlomchik, Immunobiology 5: The Immune System in Health and Disease (Garland Press, New York, 2001).
14. D. Sylvestre et al., J. Exp. Med. 184, 2385 (1996).
15. R. Clynes, J. V. Ravetch, Immunity 3, 21 (1995).
16. J. V. Ravetch, L. L. Lanier, Science 290, 84 (2000).
17. F. Nimmerjahn, P. Bruhns, K. Horiuchi, J. V. Ravetch, Immunity 23, 41 (2005).
18. Materials and methods are available as supporting material on Science Online.
19. S. Vijayasaradhi, B. Bouchard, A. N. Houghton, J. Exp. Med. 171, 1375 (1990).
20. A. Samuelsson, T. L. Towers, J. V. Ravetch, Science 291, 484 (2001).
21. N. Shushakova et al., J. Clin. Invest. 110, 1823 (2002).
22. R. Jefferis, J. Lund, Immunol. Lett. 82, 57 (2002).
23. R. L. Shields et al., J. Biol. Chem. 277, 26733 (2002).
24. T. Shinkawa et al., J. Biol. Chem. 278, 3466 (2003).
25. M. D. Hulett, P. M. Hogarth, Adv. Immunol. 57, 1 (1994).
26. -/- mice, B. Coller (Rockefeller University) for access to the Advia hematology system, and A. Savage for expert technical assistance. This work was supported by grants from the NIH to J.V.R. and from the Deutsche Forschungsgemeinschaft (NI711/2-1) and Cancer Research Institute to F.N.